is metformin a glp 1 receptor agonist GLP-1 Agonists: Increasing Effective Insulin Release Disproportionality analysis of GLP-1 receptor
Description
Delayed gastric emptying and reduced gastrointestinal (GI) motility can have different effects on drug PK dependent upon the drugs BCS category
The CV benefit is real, and it is glucose-independent
Advancements in stem cell therapy, namely pancreatic islet transplantation, have been noted, with recent trials demonstrating insulin independence in 60% of recipients after five years
It supports the efficient analysis and interpretation of extensive biological datasets, aiding in target identification, lead compound refinement, and forecasting drugtarget interactions [26]
Wilding et al., NEJM, 2021
1996;271:R848R856
